Distalmotion Expands its DEXTER US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair

Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System.

Source: GlobeNewsWire

Read more